FERRÈ, LAURA
 Distribuzione geografica
Continente #
AS - Asia 143
EU - Europa 121
NA - Nord America 77
SA - Sud America 14
OC - Oceania 1
Totale 356
Nazione #
US - Stati Uniti d'America 74
CN - Cina 49
SG - Singapore 49
IT - Italia 39
HK - Hong Kong 27
DE - Germania 25
SE - Svezia 15
BR - Brasile 13
RU - Federazione Russa 10
TR - Turchia 8
FI - Finlandia 6
GB - Regno Unito 5
IN - India 5
PL - Polonia 5
HR - Croazia 4
AT - Austria 2
CA - Canada 2
CH - Svizzera 2
JP - Giappone 2
NL - Olanda 2
AL - Albania 1
AU - Australia 1
BE - Belgio 1
EC - Ecuador 1
IE - Irlanda 1
IL - Israele 1
KR - Corea 1
LT - Lituania 1
MX - Messico 1
NO - Norvegia 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 356
Città #
Hong Kong 27
Shanghai 25
Singapore 23
Milan 21
Ashburn 10
Boardman 10
Nuremberg 8
Istanbul 7
Aurora 5
Helsinki 5
Beijing 4
Budrio 4
Falkenstein 4
Hamburg 4
Princeton 4
Bend 3
Dallas 3
Frankfurt am Main 3
Lawrence 3
Moscow 3
Olsztyn 3
Oxford 3
Pune 3
Washington 3
Zagreb 3
Council Bluffs 2
Ferrara 2
Guangzhou 2
New York 2
Ottawa 2
Pavia 2
Suita 2
São Paulo 2
Warsaw 2
Amsterdam 1
Aracaju 1
Azcapotzalco 1
Bengaluru 1
Bergamo 1
Bologna 1
Bratislava 1
Brussels 1
Campo Bom 1
Canoas 1
Carleton 1
Changsha 1
Chennai 1
College Station 1
Dublin 1
Fort Worth 1
Fribourg 1
Gelsenkirchen 1
Guarujá 1
Hwaseong-si 1
Imus 1
Ipuã 1
Itabira 1
Izmir 1
Jiaozuo 1
Jiaxing 1
Lappeenranta 1
London 1
Los Angeles 1
Maceió 1
Mariana 1
Munich 1
Oslo 1
Ourinhos 1
Quito 1
Redmond 1
Rome 1
Seattle 1
Sobral 1
Springfield 1
Sydney 1
São João del Rei 1
Tel Aviv 1
Turin 1
Verona 1
Wuhan 1
Zurich 1
Totale 256
Nome #
Characterization of the genomic profile and immune repertoire in Multiple Sclerosis patients to predict disease activity 70
DNA Methylation in the Anti-Mullerian Hormone Gene and the Risk of Disease Activity in Multiple Sclerosis 51
Transcriptional effects of fingolimod treatment on peripheral T cells in relapsing remitting multiple sclerosis patients 28
Involvement of NINJ2 Protein in Inflammation and Blood-Brain Barrier Transmigration of Monocytes in Multiple Sclerosis 27
Combining Clinical and Genetic Data to Predict Response to Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients: A Precision Medicine Approach 26
Reduction of sacsin levels in peripheral blood mononuclear cells as a diagnostic tool for spastic ataxia of Charlevoix-Saguenay 25
A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibility 24
Transcriptomic Analysis of Peripheral Monocytes upon Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients 24
Risk HLA Variants Affect the T-Cell Repertoire in Multiple Sclerosis 24
Effectiveness and baseline factors associated to fingolimod response in a real-world study on multiple sclerosis patients 23
Multiple Sclerosis Progression and Relapse Activity in Children 22
Assessment of the genetic contribution to brain magnetic resonance imaging lesion load and atrophy measures in multiple sclerosis patients 20
Prospective observational study to evaluate treatment satisfaction and effectiveness in patients with relapsing multiple sclerosis starting cladribine tablets (CLADREAL) in Italy 14
A whole-exome sequencing approach in multiplex Italian multiple sclerosis families to identify new genes involved in the disease 9
Comparative effectiveness of dimethylfumarate and fingolimod in an Italian monocentric cohort of relapsing remitting multiple sclerosis patients 7
Totale 394
Categoria #
all - tutte 3.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.930


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 1 0 0 0 1 0
2021/20225 0 1 0 2 0 0 0 2 0 0 0 0
2022/202338 8 4 1 1 2 4 2 8 5 1 0 2
2023/202495 5 2 4 8 1 8 2 14 0 5 16 30
2024/2025252 30 11 21 28 21 25 30 35 39 12 0 0
Totale 394